NCT00002920
Clinical Trial Information
Trial Number: NCT00002920 (ClinicalTrials.gov)
Disease Type:
- Breast Neoplasm - Miscellaneous
Trial Title:
A Randomized Comparison Of Medroxyprogesterone Acetate (MA) And Observation For Prevention Of Endometrial Pathology In Postmenopausal Breast Cancer Patients Treated With Tamoxifen, Phase III
Study ID:
S9630
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00002920-D2 | NCT00002920-D1 and -D2 contain the data presented in NPJ Breast Cancer (Potkul et al., NPJ, 2016; PMID 28721383). This dataset, NCT00002920-D2, contains event-level information (one row per patient per adverse event experienced on trial). |
| NCT00002920-D1 | NCT00002920-D1 and -D2 contain the data presented in NPJ Breast Cancer (Potkul et al., NPJ, 2016; PMID 28721383). This dataset, NCT00002920-D1, contains patient-level data (one row per patient), including eligibility, evaluability, treatment, demographic, and baseline information. It also contains assessment data. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®